GO:0032049 cardiolipin biosynthetic process: Mitochondrial Membrane Biogenesis, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032049 cardiolipin biosynthetic process describes the chemical reactions and pathways that form cardiolipin, 1,3-bis(3-phosphatidyl)glycerol, the signature dimeric phospholipid of the mitochondrial inner membrane.
• Cardiolipin biosynthesis occurs in mitochondria and requires sequential enzymatic steps that are spatially organized across the outer membrane, inner membrane and matrix.
• Cardiolipin is essential for mitochondrial membrane architecture, respiratory chain supercomplex stability, cristae shape and organelle dynamics.
• Defective cardiolipin biosynthesis or remodeling causes Barth syndrome, a severe X-linked disorder with cardiomyopathy, neutropenia and skeletal myopathy.
• Cardiolipin also influences non-mitochondrial processes, including inflammasome regulation and bacterial outer membrane biogenesis.
• CRISPR knockout, point-mutation, knock-in and overexpression models are powerful tools for dissecting cardiolipin biosynthetic enzymes and their disease relevance.
Description
Cardiolipin (1,3-bis(3-phosphatidyl)glycerol) is a unique dimeric phospholipid found almost exclusively in the mitochondrial inner membrane and in bacterial cytoplasmic membranes. The Gene Ontology term GO:0032049, cardiolipin biosynthetic process, encompasses the enzymatic reactions and transport steps that assemble this lipid from phosphatidylglycerol and cytidine diphosphate diacylglycerol precursors. Because cardiolipin is required for the stability of respiratory chain supercomplexes, cristae morphology and mitochondrial dynamics, its biosynthesis is a central node in mitochondrial physiology. Researchers study GO:0032049 to understand mitochondrial biogenesis, inherited mitochondrial diseases and the growing links between cardiolipin and innate immunity. The pathway is also relevant to bacterial membrane biology, where cardiolipin contributes to lipopolysaccharide transport and outer membrane integrity. This article integrates the QuickGO definition with verified PubMed literature to provide a research-grade overview of the cardiolipin biosynthetic process, its key genes, regulatory features, disease connections and experimental strategies.
cardiolipin biosynthetic process At A Glance
| GO ID | GO:0032049 |
|---|---|
| GO term | cardiolipin biosynthetic process |
| Ontology | biological_process |
| Synonym | diphosphatidylglycerol biosynthesis; diphosphatidylglycerol biosynthetic process |
| Definition | The chemical reactions and pathways resulting in the formation of cardiolipin, 1,3-bis(3-phosphatidyl)glycerol. |
| Major function | Production of cardiolipin, a dimeric phospholipid required for mitochondrial inner membrane architecture and respiratory chain function. |
| Subcellular location | Mitochondrial inner membrane and bacterial cytoplasmic membrane. |
| Key precursors | Phosphatidylglycerol and cytidine diphosphate diacylglycerol. |
| Related disease | Barth syndrome, cardiomyopathy, mitochondrial myopathy. |
What Is GO:0032049?
GO:0032049 cardiolipin biosynthetic process is defined by QuickGO as the chemical reactions and pathways resulting in the formation of cardiolipin, 1,3-bis(3-phosphatidyl)glycerol. In practice, this biological process includes the synthesis of phosphatidylglycerol and its conversion to cardiolipin through the intermediate cytidine diphosphate diacylglycerol, as well as the subsequent maturation and remodeling steps that generate the mature cardiolipin species found in mitochondrial and bacterial membranes. The term is a biological_process in the Gene Ontology and is synonymous with diphosphatidylglycerol biosynthesis and diphosphatidylglycerol biosynthetic process.
Why Is cardiolipin biosynthetic process Important in Cell Biology?
Cardiolipin biosynthesis is important because cardiolipin is indispensable for mitochondrial energy transduction, membrane remodeling and organelle dynamics. The pathway supplies the lipid environment required for respiratory chain supercomplex assembly and for the activity of mitochondrial carriers and translocases. Disruption of cardiolipin biosynthesis or its remodeling leads to Barth syndrome and contributes to cardiomyopathy, skeletal myopathy and metabolic stress. Beyond mitochondria, cardiolipin biosynthesis in bacteria supports outer membrane biogenesis and lipopolysaccharide transport, and cardiolipin can modulate inflammatory signaling by preventing LPS binding to caspase-4/11. Thus, GO:0032049 is a convergence point for mitochondrial biology, inherited disease and innate immunity.
• Provides cardiolipin for mitochondrial inner membrane architecture and cristae formation.
• Supports respiratory chain supercomplex stability and oxidative phosphorylation.
• Required for mitochondrial dynamics, including OPA1-mediated membrane remodeling.
• Defects cause Barth syndrome, a rare X-linked cardioskeletal myopathy.
• Contributes to bacterial outer membrane integrity and lipopolysaccharide transport.
• Modulates innate immune signaling by inhibiting non-canonical inflammasome activation.
• Influences monolysocardiolipin levels and mitochondrial protein interactions.
• Serves as a target for pharmacological and genetic studies of mitochondrial disease.
What Happens During cardiolipin biosynthetic process?
Phosphatidylglycerol formation
In simple terms: The cell first builds a lipid called phosphatidylglycerol, which is the starting material for cardiolipin.
The cardiolipin biosynthetic process begins with the synthesis of phosphatidylglycerol from cytidine diphosphate diacylglycerol and glycerol-3-phosphate in the mitochondrial inner membrane. This step establishes the phosphatidyl moiety that will later be used to form the dimeric cardiolipin molecule. The reaction is spatially organized within mitochondria, and the lipid intermediates are channeled between membrane compartments.
Condensation to cardiolipin
In simple terms: Two phosphatidylglycerol molecules are joined together to create cardiolipin.
The central enzymatic step of GO:0032049 is the condensation of phosphatidylglycerol with cytidine diphosphate diacylglycerol to form cardiolipin, releasing cytidine monophosphate. This reaction produces the characteristic dimeric phospholipid 1,3-bis(3-phosphatidyl)glycerol. The enzyme responsible is associated with the mitochondrial inner membrane, and its activity is coupled to the availability of lipid precursors.
Remodeling and maturation
In simple terms: After cardiolipin is made, it is reshaped into the mature forms that mitochondria actually use.
Nascent cardiolipin undergoes remodeling, including deacylation and reacylation steps that generate the mature cardiolipin species enriched in unsaturated fatty acids. Monolysocardiolipin is an intermediate in this remodeling process and interacts with mitochondrial membrane proteins. Proper remodeling is required for cardiolipin to support respiratory chain function and mitochondrial membrane dynamics.
Integration into mitochondrial membranes
In simple terms: The newly made cardiolipin is inserted into the inner mitochondrial membrane where it does its job.
Cardiolipin is integrated into the mitochondrial inner membrane, where it associates with respiratory chain complexes and other membrane proteins. This lipid environment is essential for the stability of supercomplexes and for the activity of mitochondrial carriers. Cardiolipin also promotes membrane remodeling by OPA1, linking biosynthesis to mitochondrial fusion and cristae organization.
Bacterial cardiolipin biosynthesis
In simple terms: Bacteria also make cardiolipin, and this process helps build their outer membrane.
In Gram-negative bacteria, cardiolipin biosynthesis occurs in the cytoplasmic membrane and contributes to lipopolysaccharide transport to the outer membrane. Cardiolipin aids in the assembly and function of the lipopolysaccharide transport machinery, supporting outer membrane integrity. This bacterial pathway is distinct from the mitochondrial pathway but shares the core chemistry of cardiolipin formation.
Key Genes Involved in GO:0032049 cardiolipin biosynthetic process
The following genes and proteins are central to cardiolipin biosynthesis, remodeling and mitochondrial cardiolipin function, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PGS1 | Phosphatidylglycerophosphate synthase; catalyzes an early step in phosphatidylglycerol synthesis | Target for studying mitochondrial phospholipid biogenesis |
| PTPMT1 | Phosphatidylglycerophosphate phosphatase; dephosphorylates phosphatidylglycerophosphate to phosphatidylglycerol | Knockout models reveal cardiolipin depletion effects |
| CRLS1 | Cardiolipin synthase; condenses phosphatidylglycerol and CDP-diacylglycerol to form cardiolipin | Core enzyme of GO:0032049; candidate for loss-of-function studies |
| TAZ | Tafazzin; transacylase that remodels cardiolipin and generates mature species | Mutations cause Barth syndrome; key disease gene |
| OPA1 | Dynamin-like GTPase; mediates mitochondrial membrane remodeling dependent on cardiolipin | Links cardiolipin to mitochondrial fusion and cristae |
| PLSCR3 | Phospholipid scramblase; implicated in cardiolipin distribution and mitochondrial function | Potential modifier of cardiolipin-dependent processes |
| AIFM1 | Apoptosis-inducing factor; interacts with cardiolipin in mitochondria | Connects cardiolipin to cell death pathways |
| CASP4 | Caspase-4; binds LPS and is inhibited by cardiolipin | Innate immunity link to cardiolipin |
| CASP11 | Caspase-11; non-canonical inflammasome component inhibited by cardiolipin | Mouse model for cardiolipin-inflammasome studies |
| LPTB | Lipopolysaccharide transport protein; cardiolipin aids its function | Bacterial cardiolipin biosynthesis model |
| LPTE | Lipopolysaccharide transport protein; cardiolipin supports outer membrane assembly | Target for antibacterial research |
| MLCL | Monolysocardiolipin; remodeling intermediate | Biomarker and intermediate in cardiolipin maturation |
| NDUFB | Respiratory chain subunit; requires cardiolipin for supercomplex stability | Readout for cardiolipin function |
| COX | Cytochrome c oxidase; cardiolipin-binding respiratory complex | Model for cardiolipin-protein interactions |
| ANT | Adenine nucleotide translocator; cardiolipin-dependent carrier | Mitochondrial transport studies |
| VDAC | Voltage-dependent anion channel; interacts with cardiolipin | Outer membrane cardiolipin interaction |
How Is cardiolipin biosynthetic process Regulated?
Cardiolipin biosynthesis is regulated by the availability of lipid precursors, the expression and activity of biosynthetic enzymes, and the metabolic state of the mitochondrion. Intramitochondrial phospholipid trafficking ensures that phosphatidylglycerol and cardiolipin are delivered to the correct membrane compartments. Cardiolipin levels and species composition are further controlled by remodeling enzymes such as tafazzin, which responds to the demand for mature cardiolipin. Mitochondrial dynamics and membrane remodeling by OPA1 are influenced by cardiolipin, creating feedback between lipid composition and organelle shape. In bacteria, cardiolipin biosynthesis is coordinated with lipopolysaccharide transport and outer membrane biogenesis.
cardiolipin biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TAZ | Barth syndrome; cardiolipin remodeling defect | TAZ knockout or point-mutation iPSC-derived cardiomyocytes |
| CRLS1 | Cardiolipin biosynthesis deficiency; mitochondrial dysfunction | CRLS1 knockout HeLa or HEK293 cells |
| OPA1 | Optic atrophy; mitochondrial dynamics | OPA1 knock-in or knockout fibroblasts |
| CASP4 | Non-canonical inflammasome regulation | CASP4 knockout macrophages |
| LPTB | Bacterial outer membrane integrity | LPTB mutant E. coli |
Barth syndrome and cardiolipin remodeling defects
Barth syndrome is an X-linked disorder caused by mutations in the tafazzin gene (TAZ), which is required for cardiolipin remodeling. Loss of tafazzin leads to decreased mature cardiolipin and accumulation of monolysocardiolipin, resulting in cardiomyopathy, neutropenia and skeletal myopathy. Mechano-energetic studies show that cardiolipin deficiency impairs mitochondrial respiratory function and membrane stability. This disease directly links GO:0032049 and its downstream remodeling steps to human pathology.
Cardiolipin in mitochondrial dynamics and neurodegeneration
Cardiolipin is required for OPA1-mediated membrane remodeling, and OPA1 mutations cause optic atrophy and mitochondrial fragmentation. Altered cardiolipin metabolism has been observed in neurodegenerative conditions, where mitochondrial dysfunction is a common feature. Cardiolipin also interacts with apoptosis-inducing factor and other mitochondrial proteins, influencing cell survival. These findings suggest that cardiolipin biosynthetic process genes may modify neurodegeneration risk.
Cardiolipin and innate immunity
Cardiolipin inhibits the non-canonical inflammasome by preventing lipopolysaccharide binding to caspase-4 and caspase-11. This places cardiolipin biosynthesis in the regulation of inflammatory responses to Gram-negative bacteria. In bacteria, cardiolipin aids in lipopolysaccharide transport to the outer membrane, further connecting cardiolipin to host-pathogen interactions. Dysregulated cardiolipin metabolism may therefore influence sepsis and inflammatory disease.
From cardiolipin biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of CRLS1 abolish cardiolipin biosynthesis? | CRLS1 knockout cell line |
| Does a Barth syndrome mutation alter cardiolipin species? | TAZ point-mutation knock-in cells |
| Can tagged CRLS1 reveal its submitochondrial localization? | CRLS1 knock-in with fluorescent tag |
| Does OPA1 require cardiolipin for membrane remodeling? | OPA1 overexpression in cardiolipin-deficient cells |
| Does cardiolipin inhibit caspase-4 activation? | CASP4 overexpression with cardiolipin supplementation |
| Does cardiolipin affect bacterial LPS transport? | LPTB overexpression or mutant strains |
How to Study the cardiolipin biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lipidomics (LC-MS) | Cardiolipin and monolysocardiolipin species | Quantify biosynthesis and remodeling defects |
| Fluorescence microscopy | Mitochondrial cristae and membrane dynamics | Assess OPA1-dependent remodeling |
| Respirometry | Oxygen consumption and respiratory chain activity | Evaluate mitochondrial function in mutants |
| CRISPR knockout screening | Gene essentiality and modifiers | Identify cardiolipin pathway regulators |
| RNA-seq | Transcriptional changes | Map compensatory responses |
| Proteomics | Protein interactions with cardiolipin | Identify cardiolipin-binding proteins |
| Bacterial genetics | Outer membrane integrity | Study cardiolipin in LPS transport |
| Inflammasome assays | Caspase-4/11 activation | Test cardiolipin inhibition of LPS binding |
Lipidomics and mass spectrometry
Mass spectrometry-based lipidomics is the primary method to quantify cardiolipin and monolysocardiolipin species in cells and tissues. This approach can resolve the acyl chain composition of cardiolipin and detect remodeling defects in Barth syndrome models. Lipidomic profiling is often combined with stable isotope labeling to trace biosynthetic flux through GO:0032049.
Fluorescence imaging of mitochondrial membranes
Live-cell fluorescence microscopy using cardiolipin-binding dyes or tagged mitochondrial proteins reveals cristae morphology and membrane dynamics. Imaging of OPA1 and cardiolipin co-localization can show how cardiolipin supports membrane remodeling. Super-resolution techniques are useful for assessing inner membrane architecture in knockout models.
Respirometry and mitochondrial function assays
Seahorse respirometry and high-resolution oxygraphy measure oxygen consumption to assess the functional consequences of cardiolipin deficiency. These assays detect defects in respiratory chain supercomplex activity caused by altered cardiolipin biosynthesis. They are commonly used in TAZ and CRLS1 mutant models.
CRISPR screening and transcriptomics
Genome-wide CRISPR knockout screens can identify genes that modify cardiolipin dependence or mitochondrial fitness. RNA sequencing of cardiolipin-deficient cells reveals transcriptional responses and compensatory pathways. These methods help prioritize candidate genes in the cardiolipin biosynthetic process for follow-up studies.
How CRISPR Can Be Used to Study GO:0032049 cardiolipin biosynthetic process
Knockout
CRISPR knockout of CRLS1 or PGS1 can abolish cardiolipin biosynthesis, providing a clean background to study downstream effects on mitochondrial function and membrane architecture. Knockout models are also used to test whether cardiolipin is required for OPA1-mediated remodeling. These models help validate the essentiality of GO:0032049 genes in cell lines and primary cells.
Point Mutation
Point mutations in TAZ that mimic Barth syndrome patient alleles can be introduced by CRISPR to study cardiolipin remodeling defects in an isogenic background. Such models reveal how specific amino acid changes affect tafazzin activity and cardiolipin species composition. Point-mutation models are valuable for testing pharmacological chaperones or substrate analogs.
Knock-in
Knock-in of fluorescent or affinity tags into endogenous CRLS1 or TAZ allows visualization and purification of cardiolipin biosynthetic enzymes. Tagged knock-in models enable live-cell imaging of enzyme localization and interaction partners. They also facilitate proteomic identification of cardiolipin-protein complexes.
Overexpression
Overexpression of CRLS1 or TAZ can increase cardiolipin levels and rescue mitochondrial defects in disease models. Overexpression of OPA1 in cardiolipin-deficient cells tests whether increased fusion machinery compensates for lipid loss. Overexpression of CASP4 with cardiolipin supplementation can probe inflammasome regulation.
How EDITGENE Supports cardiolipin biosynthetic process Research
Researchers studying cardiolipin biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in cardiolipin production, mitochondrial function or disease phenotypes. EDITGENE provides CRISPR-based cell model services that enable precise genetic manipulation of cardiolipin pathway genes in relevant cell types.
Contact EDITGENE today to design your custom CRISPR model for cardiolipin biosynthetic process research.
Frequently Asked Questions About cardiolipin biosynthetic process
What is cardiolipin biosynthetic process?
Cardiolipin biosynthetic process (GO:0032049) is the set of chemical reactions and pathways that form cardiolipin, 1,3-bis(3-phosphatidyl)glycerol, primarily in the mitochondrial inner membrane and bacterial cytoplasmic membrane.
What genes are involved in cardiolipin biosynthetic process?
Key genes include CRLS1, PGS1, PTPMT1, TAZ, OPA1 and, in bacteria, LPTB and LPTE, based on published studies.
Where does cardiolipin biosynthesis occur?
In eukaryotic cells, cardiolipin biosynthesis occurs in mitochondria, with enzymes associated with the inner membrane and matrix. In Gram-negative bacteria, it occurs in the cytoplasmic membrane.
What is the function of cardiolipin?
Cardiolipin is required for mitochondrial inner membrane architecture, respiratory chain supercomplex stability, cristae formation and mitochondrial dynamics.
What disease is caused by defective cardiolipin biosynthesis?
Defective cardiolipin remodeling causes Barth syndrome, an X-linked disorder with cardiomyopathy, neutropenia and skeletal myopathy.
How is cardiolipin measured in the lab?
Cardiolipin and monolysocardiolipin species are typically measured by mass spectrometry-based lipidomics, often combined with fluorescence imaging and respirometry.
Can CRISPR be used to study cardiolipin biosynthesis?
Yes, CRISPR knockout, point-mutation, knock-in and overexpression models are widely used to dissect cardiolipin biosynthetic genes and their disease relevance.
What is the role of TAZ in cardiolipin biosynthesis?
TAZ encodes tafazzin, a transacylase that remodels cardiolipin into mature species; TAZ mutations cause Barth syndrome.
How does cardiolipin affect the immune system?
Cardiolipin inhibits the non-canonical inflammasome by preventing LPS binding to caspase-4 and caspase-11.
What is the difference between cardiolipin and monolysocardiolipin?
Monolysocardiolipin is a remodeling intermediate formed during cardiolipin maturation; its accumulation is a hallmark of Barth syndrome.
Conclusion
GO:0032049 cardiolipin biosynthetic process is a fundamental mitochondrial and bacterial pathway that produces the dimeric phospholipid cardiolipin, a molecule essential for membrane architecture, respiratory chain function and organelle dynamics. Defects in this pathway or in downstream remodeling cause Barth syndrome and contribute to broader mitochondrial and inflammatory pathologies. Continued research using CRISPR-based models and lipidomics will clarify how cardiolipin biosynthesis is regulated and how it can be targeted therapeutically.
References
- 1. Mårtensson CU et al.. 2017. Effects of lipids on mitochondrial functions.. Biochim Biophys Acta Mol Cell Biol Lipids 1862(1):102-113 PMID: 27349299
- 2. Tatsuta T et al.. 2017. Intramitochondrial phospholipid trafficking.. Biochim Biophys Acta Mol Cell Biol Lipids 1862(1):81-89 PMID: 27542541
- 3. Thatavarthy S et al.. 2025. Cardiolipin dynamics promote membrane remodeling by mitochondrial OPA1.. Nat Commun 16(1):8685 PMID: 41027961
- 4. Dudek J et al.. 2022. Mechano-energetic aspects of Barth syndrome.. J Inherit Metab Dis 45(1):82-98 PMID: 34423473
- 5. Pizzuto M et al.. 2025. Cardiolipin inhibits the non-canonical inflammasome by preventing LPS binding to caspase-4/11.. EMBO J 44(16):4419-4442 PMID: 40670771
- 6. Douglass MV et al.. 2021. Cardiolipin aids in lipopolysaccharide transport to the gram-negative outer membrane.. Proc Natl Acad Sci U S A 118(15) PMID: 33833055
- 7. Duncan AL. 2020. Monolysocardiolipin (MLCL) interactions with mitochondrial membrane proteins.. Biochem Soc Trans 48(3):993-1004 PMID: 32453413
- 8. Paradies G et al.. 2019. Role of Cardiolipin in Mitochondrial Function and Dynamics in Health and Disease: Molecular and Pharmacological Aspects.. Cells 8(7) PMID: 31315173
